Although albumin fusion technology has been widely used to extend the half-lives of hormones, cytokines, and antibody fragments, very few data are available so far about its application in targeted delivery of protein drugs to inflamed joints for RA treatment. Here, ALB is linked to rheumatoid arthritis.